发明名称 BIOSYNTHESIS OF HIF
摘要 <p>The present invention relates to a method of identifying an agent (e.g., petide, small molecule) that alters (partially, completely ) the activity (function, expression) of HIF. In one embodiment, the method of identifying an agent that alters (e.g., inhibits, enhances) the activity of HIF comprises contacting a molecule in the HIF biosynthetic pathway (e.g., a precursor of HIF, such as a steroid precursor; an enzyme) with an agent to be assessed and determining whether the activity of the molecule (function, expression) is altered in the presence of the agent when compared to the activity of the molecule in the absence of the agent. The invention is also related method of treatment using such agents; and methods of monitoring the biosynthetic pathway of OLC/HIF. In particular, the invention is related to agent, treatments, and diagnostics for diseases such a hypertension and heart failure.</p>
申请公布号 WO2004000328(A1) 申请公布日期 2003.12.31
申请号 WO2003US19645 申请日期 2003.06.20
申请人 THE GENERAL HOSPITAL CORPORATION;THE BRIGHAM AND WOMEN'S HOSPITAL, INC.;HAUPERT, GARNER T., JR.;GULLANS, STEVEN, R. 发明人 HAUPERT, GARNER T., JR.;GULLANS, STEVEN, R.
分类号 A61K38/00;C12Q1/26;C12Q1/533;G01N33/74;(IPC1-7):A61K31/70;G01N33/53;A61K39/395 主分类号 A61K38/00
代理机构 代理人
主权项
地址